dpp-4 inhibitor and glp-1 receptor agonist combination not recommended guideline do combine inhibitors with agonists guidance What classes of diabetes Lesson: A Clinical Overview of

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users

Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years

Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss

99%+ purity, COA verified

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.